AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.560
-0.090 (-2.47%)
At close: Dec 5, 2025, 4:00 PM EST
3.620
+0.060 (1.69%)
After-hours: Dec 5, 2025, 7:59 PM EST
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.07 billion as of December 5, 2025. Its market cap has increased by 36.14% in one year.
Market Cap
1.07B
Enterprise Value
712.18M
1-Year Change
36.14%
Ranking
Category
Stock Price
$3.56
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.07B, a decrease of -93.20%. That is a compound annual growth rate of -41.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.09B | 26.25% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |